Does Your Drug Plan Cover Ozempic or Wegovy in BC? What Chilliwack Patients Need to Know in 2026

Drug costs are rising — and BC patients are feeling it

At the BC Pharmacy Association's annual conference this past weekend,

insurance leaders from Pacific Blue Cross and Sun Life Health sat alongside

BC Ministry of Health officials to discuss a single uncomfortable reality:

drug costs are climbing faster than any plan — public or private — was

built to absorb.

Specialty medications now account for roughly one-third of private drug

plan spending in Canada, despite being used by only about 2% of

claimants. Some therapies now exceed $250,000 per patient per year.

And in the middle of all of it sits one category that BC patients ask

about more than almost anything else: GLP-1 medications like Ozempic

and Wegovy.

Here is what you actually need to know if you are a patient in BC.

---

What BC PharmaCare covers — and what it does not

BC PharmaCare covers Ozempic (semaglutide) for Type 2 diabetes only —

specifically as a second-line therapy when metformin has not been effective.

It does not cover Ozempic or Wegovy for weight loss. As of early 2026,

no Canadian provincial health plan covers Wegovy for weight management.

Negotiations between the pan-Canadian Pharmaceutical Alliance and Novo

Nordisk ended without agreement in December 2025, meaning public

coverage for weight loss remains off the table for now.

The one important exception: Canada's Drug Agency issued a recommendation

in July 2025 that public plans should consider covering Wegovy for adults

with a BMI of 27 or greater who also have **established cardiovascular

disease**. BC's Ministry of Health is reviewing its formulary in response —

but no decision has been confirmed.

Bottom line for most BC patients: if you need Ozempic for Type 2

diabetes, PharmaCare likely has you covered. If you want it for weight loss,

you are paying out of pocket — roughly $250–$300 per month for Ozempic,

or $400–$570 per month for Wegovy.

---

What about private drug plans?

Private insurers are navigating this carefully. At the BCPhA conference,

both Pacific Blue Cross and Sun Life Health acknowledged that GLP-1

medications are reshaping workplace benefit plans — because obesity is

increasingly recognized as a chronic disease, not a lifestyle choice.

Some private plans do cover GLP-1s with prior authorization — meaning

your doctor or pharmacist needs to submit documentation showing clinical

need. Coverage varies widely depending on your employer's plan.

What is also changing: insurers are responding to the cost pressure by

introducing annual or lifetime maximums on drug benefits. As Anar Dossa

of Pacific Blue Cross described at the conference, a single $250,000

drug claim can trigger an employer to restructure their entire benefit

plan at renewal.

What this means for you: your coverage today may not be your coverage

next year. It is worth reviewing your plan details — or asking your

pharmacist to help you understand what you are actually entitled to.

---

Generic semaglutide is coming — and it matters

Core semaglutide patents expired in Canada in early 2026. Health Canada

is currently reviewing applications from generic manufacturers including

Sandoz, Apotex, and Teva. Generic versions are expected to reach

pharmacies in mid-to-late 2026, which could significantly reduce

out-of-pocket costs for patients paying without coverage.

This is a development worth watching. Ask your Pill4Me pharmacist to

keep you informed as this changes.

---

BC's biosimilars track record shows what is possible

One bright spot in the drug cost conversation: British Columbia's

Biosimilars Initiative has already demonstrated that evidence-based

switching programs can generate massive savings without compromising

patient outcomes.

Pacific Blue Cross followed BC's lead and transitioned all of its plan

sponsors to biosimilars — a move that, according to their VP of pharmacy

services, saved hundreds of millions of dollars. The principle is the

same one pharmacists apply every day: the right drug, for the right

patient, at a cost the system can sustain.

---

How your Pill4Me pharmacist can help

Drug coverage in BC is genuinely complex right now — and it is changing.

Your Pill4Me pharmacist can:

or your private plan

reduce your costs

opportunities to simplify your therapy

obesity, or other chronic conditions

You do not need an appointment. Walk in, and ask.

---

Pill4Me Pharmacy

101-5625 Promontory Rd, Chilliwack, BC V2R 4M5

(604) 705-3644 | hello@pill4.me

*Sources: BC PharmaCare formulary; Canada's Drug Agency (CDA-AMC) July 2025

recommendation; BCPhA Annual Conference May 2026; TELUS Health Drug Cost

Trends Report 2024; CBC News coverage of BC obesity medication access.*